XML 58 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Segment Information | 12 Months Ended
--- | ---
Dec. 29, 2017
Segment Reporting [Abstract] |
Segment Information | SEGMENT INFORMATION We operate in one business segment which focuses on discovery, development and commercialization of new medicines to improve care and outcomes for people with cancer. Our Chief Executive Officer, as the chief operating decision-maker, manages and allocates resources to our operations on a total consolidated basis. Consistent with this decision-making process, our Chief Executive Officer uses consolidated, single-segment financial information for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. Enterprise-wide disclosures about product sales, revenues from major customers, revenues and long-lived assets by geographic area are presented below. Net product revenues by product were as follows (dollars in thousands):
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
CABOMETYX | $ | 324,000 |  |  | $ | 93,481 |  |  | $ | — |
COMETRIQ | 25,008 |  |  | 41,894 |  |  | 34,158 |
Net product revenues | $ | 349,008 |  |  | $ | 135,375 |  |  | $ | 34,158 |
The percentage of total revenues recognized by customer that represent 10% or more of total revenues was as follows:
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
Diplomat Specialty Pharmacy | 18 | % |  | 33 | % |  | 83 | %
Caremark L.L.C. | 16 | % |  | 9 | % |  | — | %
Ipsen | 15 | % |  | 17 | % |  | — | %
Accredo Health, Incorporated | 11 | % |  | 9 | % |  | — | %
Affiliates of McKesson Corporation | 11 | % |  | 7 | % |  | — | %
Revenues earned by geographic region were as follows (dollars in thousands):
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
U.S. | $ | 367,906 |  |  | $ | 140,709 |  |  | $ | 33,869 |
Europe | 69,792 |  |  | 35,745 |  |  | 3,303 |
Rest of the world | 14,779 |  |  | 15,000 |  |  | — |
Net product revenues are attributed to regions based on ship-to location and Collaboration revenues are attributed to regions based on the location of the collaboration partner. We recorded a $0.2 million loss, a $0.2 million loss and a $0.1 million gain relating to foreign exchange fluctuations for the years ended December 31, 2017, 2016 and 2015, respectively. All of our long-lived assets are located in the U.S.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration